Calumet Provides Preliminary Fourth Quarter 2024 Selected Financial Results
1. Calumet expects a net loss of $24-$54 million for Q4 2024. 2. Adjusted EBITDA projected between $45 million and $60 million. 3. Strategic progress includes closing of a DOE loan and operational milestones. 4. Capex is estimated at $50-$70 million for specialties and $10-$20 million for maintenance. 5. Insurance proceeds contributed $20 million to financial results, aiding losses.